Discovery of a Novel Series of Imidazopyrazine Derivatives as Potent SHP2 Allosteric Inhibitors

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors2019 · 83 citations
2. 2The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors2001 · 177 citations
3. 3SHP-2 Regulates SOCS-1-mediated Janus Kinase-2 Ubiquitination/Degradation Downstream of the Prolactin Receptor2003 · 86 citations
4. 46-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors2019 · 86 citations
5. 5Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition2018 · 171 citations